Piramal Group
Tracked across 4 events · 42 articles · First seen Dec 19, 2025 · Last active May 28, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Piramal Group announced its Q4 and full-year FY26 results, reporting a decline in revenue and EBITDA but expressing optimism for FY27 growth across its businesses. The company also recognized an impairment loss of ₹176 crore.
Apr 28, 2026 · 14 articles
Business
Impact: Piramal Group's subsidiary, Piramal Enterprises — Piramal Pharma Solutions, entered a strategic collaboration, which is expected to positively impact the parent company's market position and offerings.
Apr 16, 2026 · 11 articles
Business
Impact: Piramal Group, as the parent company of Piramal Enterprises — Piramal Pharma Solutions, benefits from the expansion of its subsidiary's manufacturing capabilities, which supports its overall growth strategy in the pharmaceutical sector.
May 13, 2026 · 11 articles
Business
Impact: Piramal Group previously invested in the Shriram Group and sold its pharmaceutical business.
Dec 19, 2025 · 6 articles
ERGEN INTELLIGENCE
Track Piramal Group live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard